HDAC inhibitor suppresses proliferation and tumorigenicity of drug-resistant chronic myeloid leukemia stem cells through regulation of hsa-miR-196a targeting BCR/ABL1

Autor: Bamodu, Oluwaseun Adebayo, Kuo, Kuang-Tai, Yuan, Li-Ping, Cheng, Wei-Hong, Lee, Wei-Hwa, Ho, Yuan-Soon, Chao, Tsu-Yi, Yeh, Chi-Tai
Zdroj: In Experimental Cell Research 15 September 2018 370(2):519-530
Databáze: ScienceDirect
Externí odkaz: